Impella CP improves survival in selected cardiogenic shock patients while routine early VA-ECMO lacks clear benefit
New data clarifies the role of heart pumps in shock
This narrative review examines the use of VA-ECMO and microaxial-pump strategies in patients with cardiogenic shock and ST-elevation myocard…
New research looks at how heart pumps and bypass machines help patients with severe heart damage after a heart attack.
Beta-blocker outcomes vary by myocardial infarction type and left ventricular ejection fraction
Trial shows different heart medication effects based on heart attack type
This prespecified subgroup analysis examined the impact of beta-blockers on primary outcomes in patients with STEMI and NSTEMI. The findings…
New data suggests that beta-blockers may have different impacts on patients depending on the specific type of heart attack they experience.
Ticagrelor monotherapy after primary PCI shows 3.1% MACCE versus 2.0% in DAPT group
Trial shows ticagrelor alone may reduce bleeding after heart attack
This pilot randomized controlled trial of 200 STEMI patients compared ticagrelor monotherapy to ticagrelor plus aspirin (DAPT) after primary…
A new trial looks at whether using one blood thinner instead of two can reduce bleeding risks for patients after a heart attack.
Persistent microvascular obstruction predicts higher MACE and death risks following ST-segment elevation myocardial infarction
Persistent heart muscle damage after heart attack increases risk
This meta-analysis of 2180 patients with STEMI identifies persistent microvascular obstruction as a significant prognostic indicator. Persis…
Patients with lasting microvascular obstruction after a heart attack face higher risks of death and major complications compared to those wi…
Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
Ticagrelor Shows Lower Mortality Risk Than Clopidogrel for Heart Patients
This meta-analysis of 31,729 adult STEMI patients post-PCI found that ticagrelor significantly reduced all-cause mortality (OR = 0.64) and m…
A large analysis of over 31,000 patients suggests ticagrelor may lower mortality and heart attack risks compared to clopidogrel after a hear…
Tocilizumab shows early anti-inflammatory effects but no significant clinical benefit in STEMI or NSTEMI
Tocilizumab shows early signs of heart protection in heart attacks
This meta-analysis of randomized controlled trials evaluated tocilizumab for patients with STEMI and NSTEMI. While the intervention showed a…
A new review looks at how the drug tocilizumab affects patients with heart attacks, showing some early signs of reduced inflammation.
Staged revascularization shows no significant difference versus immediate revascularization for major adverse cardiovascular events in STEMI and MVD patients
Timing of heart surgery does not change survival for a specific heart attack group
This meta-analysis reviewed 5077 patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease comparing …
A large review found that waiting for staged heart surgery did not improve survival or reduce heart attacks compared to immediate surgery fo…
Prehospital unfractionated heparin bolus improved TIMI flow in STEMI without increasing bleeding risk
Pretreatment with UFH improves artery flow for STEMI patients without extra bleeding risk
This single-center randomized trial evaluated pretreatment with unfractionated heparin in patients with ST-segment-elevation myocardial infa…
Giving unfractionated heparin early at first medical contact improved artery flow in heart attack patients without increasing bleeding risk.
Meta-analysis shows no significant difference between immediate and staged revascularization for STEMI with multivessel disease
Immediate heart procedure shows no major benefit over staged approach for heart attack patients
This systematic review and meta-analysis evaluated patients with ST-elevation myocardial infarction and multivessel disease undergoing immed…
A large review of heart attack patients with multiple blocked arteries found that doing the full procedure right away did not lower the risk…
Family history, prior arrhythmia, and anterior infarct location independently raise risk of ventricular fibrillation in STEMI patients
Family history and heart attack location raise risk of dangerous heart rhythms in young patients
This meta-analysis of 1807 cases and 2923 controls confirms that family history of sudden death, previous atrial fibrillation, and anterior …
A large study found that family history of sudden death, past atrial fibrillation, and front heart attacks increase the chance of dangerous …
Rescue PCI after failed fibrinolysis linked to worse outcomes in STEMI compared to scheduled angiography
Rescue PCI after failed clot-busting drugs caused worse heart outcomes than planned angiography
This pre-specified analysis of the STREAM-2 RCT compared rescue PCI after failed fibrinolysis with scheduled angiography in 583 patients wit…
Patients needing emergency heart catheterization after clot-busting drugs fared worse than those who received planned procedures, with highe…
In STEMI patients, admission CK-MB and CPK elevation predicts adverse outcomes in a small cross-sectional study
Old Heart Tests Still Save Lives
This cross-sectional study evaluated 15 patients with ST-elevation myocardial infarction (STEMI) at the Punjab Institute of Cardiology, Laho…
Imagine waking up with crushing chest pain.
Research across Myocardial ischemia
Related studies from across the Myocardial ischemia family.
Individualized mechanical circulatory support is necessary as increased hemodynamic support does not uniformly improve survival
Mechanical Support for Cardiogenic Shock Does Not Uniformly Improve Survival
This mini review examines the role of short-term mechanical circulatory support (MCS) in patients with cardiogenic shock, including those wi…
Newer reviews suggest that while mechanical support helps heart function, it does not always lead to better survival rates for patients in c…
Qili Qiangxin plus conventional medicine improves surrogate markers in heart failure after myocardial infarction
Qili Qiangxin May Improve Heart Function After Heart Attack
This meta-analysis of 1391 patients found that Qili Qiangxin combined with conventional Western medicine led to greater reductions in NT-pro…
Adding Qili Qiangxin to standard medicine may improve heart function and quality of life for patients following a heart attack.
OMI/NOMI approach increases immediate invasive management to 45.4% compared to 13.6% in myocardial infarction
New approach helps doctors find blocked heart arteries more quickly during emergencies
This multicenter randomized controlled trial substudy evaluated 4398 adult patients with myocardial infarction to compare the OMI/NOMI appro…
A new way of looking at heart attacks helps doctors find blocked arteries faster, leading to quicker treatment for patients in need.
NLRP3 inflammasome activation serves as a molecular bridge between myocardial infarction and depression
Inflammasome Activation Links Heart Attacks and Depression
This systematic review examines the role of the NLRP3 inflammasome in the link between myocardial infarction and depression. The authors con…
A specific inflammatory pathway called NLRP3 may act as a bridge between heart attacks and depression, potentially offering a new target for…
Beta-blocker therapy shows no significant reduction in primary composite outcomes for patients with LVEF ≥ 40%
Beta-blocker therapy shows mixed results for heart attack patients
This meta-analysis of 18,504 patients with acute myocardial infarction and LVEF ≥ 40% found no significant reduction in the primary composit…
New data suggests beta-blockers may only show a significant benefit for heart attack patients with specific levels of heart muscle function.
Naoxintong Supplementation Reduces Heart Failure Risk Following Acute Myocardial Infarction
New treatment may lower heart failure risk after heart attack
A randomized trial suggests that adding Naoxintong to standard therapy significantly reduces heart failure incidence and MACE rates post-AMI…
A new study shows that adding a herbal formula to standard care can significantly reduce heart failure risk for patients after a heart attac…
Clinical signs, imaging, and biomarkers facilitate risk stratification for cardiac rupture in myocardial infarction
New tools help doctors predict life-threatening heart ruptures after heart attacks
This mini review synthesizes clinical warning signs, point-of-care imaging, and biomarker trajectories to stratify risk of cardiac rupture i…
Doctors are developing a new four-step plan to spot early warning signs of heart rupture, a condition where the heart muscle tears during a …
Intravenous nicorandil did not significantly reduce primary composite outcomes in patients with STEMI
Trial shows intravenous nicorandil does not improve heart attack outcomes
This randomized controlled trial of 1,503 patients with STEMI found no significant difference in the primary composite outcome between intra…
A large trial of over 1,500 patients found that the drug nicorandil did not improve primary outcomes for those with a heart attack.
DeepSeek AI generates guideline-conforming exercise prescriptions for myocardial infarction, heart failure, and atrial fibrillation
AI Shows Potential for Creating Heart Health Exercise Plans
This guideline-based simulation study evaluates the use of the DeepSeek model to generate exercise prescriptions for patients with myocardia…
A simulation study shows that AI can generate safe, guideline-based exercise plans for patients with heart conditions like heart failure and…
Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI Patients
Physiology guided heart procedures show lower risk of major events
Physiology-guided revascularization significantly reduces major adverse cardiac events and improves safety profiles compared to traditional …
A large international trial shows that using functional imaging to guide heart artery procedures may lower the risk of stroke and heart atta…
High-intensity statin adherence correlates with greater LDL-C reductions and improved plaque stability post-AMI
High-Intensity Statins Show Better Results for Heart Patients Following Heart Attack
This randomized controlled trial sub-study of 255 patients with acute myocardial infarction evaluated high-intensity statin therapy. Adheren…
Patients who strictly followed their high-intensity statin regimen after a heart attack showed significantly better improvements in heart he…
GLP-1 receptor agonists reduce MACE (HR 0.69) and all-cause mortality (HR 0.67) in Type 2 Diabetes
GLP-1 medications show promise for heart health in diabetes
This meta-analysis of 37,393 patients with Type 2 Diabetes and myocardial infarction-defined populations found that GLP-1 receptor agonists …
A large review of over 37,000 patients suggests GLP-1 medications may lower heart failure risks for those with Type 2 Diabetes.
Questions about ST-Elevation Myocardial Infarction
Does having a family history of sudden death make ventricular fibrillation more likely in STEMI?
Yes, a family history of sudden death independently raises the odds of ventricular fibrillation during a first STEMI by about 60%, according to a large meta-analysis.
Full answer →All ST-Elevation Myocardial Infarction Articles
- Impella CP improves survival in selected cardiogenic shock patients while routine early VA-ECMO lacks clear benefit
- Beta-blocker outcomes vary by myocardial infarction type and left ventricular ejection fraction
- Ticagrelor monotherapy after primary PCI shows 3.1% MACCE versus 2.0% in DAPT group
- Persistent microvascular obstruction predicts higher MACE and death risks following ST-segment elevation myocardial infarction
- Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
- Tocilizumab shows early anti-inflammatory effects but no significant clinical benefit in STEMI or NSTEMI
- Staged revascularization shows no significant difference versus immediate revascularization for major adverse cardiovascular events in STEMI and MVD patients
- Prehospital unfractionated heparin bolus improved TIMI flow in STEMI without increasing bleeding risk
- Meta-analysis shows no significant difference between immediate and staged revascularization for STEMI with multivessel disease
- Family history, prior arrhythmia, and anterior infarct location independently raise risk of ventricular fibrillation in STEMI patients
- Rescue PCI after failed fibrinolysis linked to worse outcomes in STEMI compared to scheduled angiography
- In STEMI patients, admission CK-MB and CPK elevation predicts adverse outcomes in a small cross-sectional study
- STEMI guidelines rely heavily on moderate and low-quality evidence, meta-analysis finds
- CTO PCI does not affect diastolic coupling in STEMI patients; elevated baseline LACI predicts mortality